Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies
Effectiveness of levetiracetam (LEV) in treatment of typical benign rolandic epilepsy and variants of benign idiopathic focal epilepsies was studied in 32 children (mean age 10.6 years, range 4-14) by researchers at Epilepsy Centre for Children and Young People, Vogtareuth, Germany.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
2010-03-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/806 |
| Summary: | Effectiveness of levetiracetam (LEV) in treatment of typical benign rolandic epilepsy and variants of benign idiopathic focal epilepsies was studied in 32 children (mean age 10.6 years, range 4-14) by researchers at Epilepsy Centre for Children and Young People, Vogtareuth, Germany. |
|---|---|
| ISSN: | 1043-3155 2166-6482 |